⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31478111 | 0.97 | — | — | |
| SCHEMBL4194907 | 0.67 | — | — | |
| SCHEMBL791418 | 0.67 | — | — | |
| SCHEMBL7454334 | 0.63 | — | — | |
| SCHEMBL10766547 | 0.63 | — | — | |
| SCHEMBL3899388 | 0.63 | — | — | |
| SCHEMBL5380749 | 0.63 | — | — | |
| SCHEMBL596987 | 0.63 | — | — | |
| SCHEMBL1755701 | 0.62 | — | — | |
| SCHEMBL5020014 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011015646-A2 | FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS | NOSCIRA, S.A. (ES) | 2011-02-10 | — | — | WO | claimed |
| US-20090203745-A1 | HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF | JERINI AG (DE) | 2009-08-13 | — | — | US | claimed |
| EP-2024357-A2 | NEW HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF | Jereni AG (DE) | 2009-02-18 | — | — | EP | claimed |
| EP-1960399-A1 | PYRROLOPYRIDINES AS KINASE INHIBITORS | Pfizer Italia S.r.l. (IT) | 2008-08-27 | — | — | EP | claimed |
| WO-2007131764-A2 | NEW HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF | JERINI AG (DE) | 2007-11-22 | — | — | WO | claimed |
| WO-2007054508-A1 | PYRROLOPYRIDINES AS KINASE INHIBITORS | PFIZER ITALIA SRL (IT) | 2007-05-18 | — | — | WO | claimed |
| US-6521646-B1 | Integrin inhibitors | MERCK PATENT GMBH (DE) | 2003-02-18 | — | — | US | claimed |
| US-20260049991-A1 | SINGLE-MOLECULE PEPTIDE SEQUENCING USING GUANIDINYLATING AGENTS | GLYPHIC BIOTECHNOLOGIES INC (US) | 2026-02-19 | — | — | US | disclosed |
| EP-4655289-A1 | SINGLE-MOLECULE PEPTIDE SEQUENCING USING GUANIDINYLATING AGENTS | Glyphic Biotechnologies, Inc. (US) | 2025-12-03 | — | — | EP | disclosed |
| US-20250340538-A1 | IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 | PERHA PHARMACEUTICALS (FR) | 2025-11-06 | — | — | US | disclosed |
| US-20250340539-A1 | IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1, AND/OR CLK4 | PERHA PHARMACEUTICALS (FR) | 2025-11-06 | — | — | US | disclosed |
| EP-4422747-A1 | IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 | Perha Pharmaceuticals (FR) | 2024-09-04 | — | — | EP | disclosed |
| EP-4422753-A1 | IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 | Perha Pharmaceuticals (FR) | 2024-09-04 | — | — | EP | disclosed |
| EP-2024357-A2 | NEW HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF | Jereni AG (DE) | 2009-02-18 | — | — | EP | disclosed |
| WO-2007131764-A2 | NEW HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF | JERINI AG (DE) | 2007-11-22 | — | — | WO | disclosed |
| US-6521646-B1 | Integrin inhibitors | MERCK PATENT GMBH (DE) | 2003-02-18 | — | — | US | disclosed |
| EP-1208088-A2 | FLUORENE DERIVATIVES AS INTEGRIN INHIBITORS | MERCK PATENT GmbH (DE) | 2002-05-29 | — | — | EP | disclosed |
| EP-1169306-A1 | DIBENZOAZULENE DERIVATIVES FOR TREATING THROMBOSIS, OSTEOPOROSIS, ARTERIOSCLEROSIS | MERCK PATENT GmbH (DE) | 2002-01-09 | — | — | EP | disclosed |
| WO-2001010841-A2 | FLUORENE DERIVATIVES AS INTEGRIN INHIBITORS | MERCK PATENT GMBH (DE) | 2001-02-15 | — | — | WO | disclosed |
| WO-2000063178-A1 | DIBENZOAZULENE DERIVATIVES FOR TREATING THROMBOSIS, OSTEOPOROSIS, ARTERIOSCLEROSIS | MERCK PATENT GMBH (DE) | 2000-10-26 | — | — | WO | disclosed |